M. Maciuszek

Synthesis and evaluation of novel cyclopentane urea FPR2 agonists and their potential application in the treatment of cardiovascular inflammation.

O. Soehnlein, M. Perretti, A. Ortega-Gómez, 2021, European journal of medicinal chemistry.

Design, synthesis, and biological evaluation of novel pyrrolidinone small-molecule Formyl peptide receptor 2 agonists.

O. Soehnlein, M. Perretti, G. Nicolaes, 2021, European journal of medicinal chemistry.

Discovery and Structure–Activity Relationships of N‐Aryl 6‐Aminoquinoxalines as Potent PFKFB3 Kinase Inhibitors

M. Jurzak, M. Nowak, M. Kujawa, 2018, ChemMedChem.

2-Nitroimidazole-ruthenium polypyridyl complex as a new conjugate for cancer treatment and visualization.

Olga Mazuryk, M. Brindell, G. Stochel, 2014, Journal of inorganic biochemistry.

Recent advances in the design and development of formyl peptide receptor 2 (FPR2/ALX) agonists as pro-resolving agents with diverse therapeutic potential.

E. Brennan, C. Godson, Antonino Cacace, 2021, European journal of medicinal chemistry.

Synthesis of amide and sulfonamide substituted N-aryl 6-aminoquinoxalines as PFKFB3 inhibitors with improved physicochemical properties.

M. Jurzak, M. Nowak, M. Kujawa, 2019, Bioorganic & medicinal chemistry letters.

Discovery and Structure-Activity Relationships of N-Aryl 6-Aminoquinoxalines as Potent PFKFB3 Kinase Inhibitors.

M. Jurzak, M. Nowak, M. Kujawa, 2018 .

Human PFKFB3 in complex with a N-Aryl 6-Aminoquinoxaline inhibitor 4

M. Nowak, M. Mikulski, H. Eggenweiler, 2019 .